Searched for: in-biosketch:yes
person:shuffl01
Fetal heart rate, heart rate variability, and heart rate/movement coupling in the Safe Passage Study
Shuffrey, Lauren C; Myers, Michael M; Odendaal, Hein J; Elliott, Amy J; du Plessis, Carlie; Groenewald, Coen; Burd, Larry; Angal, Jyoti; Nugent, J David; Isler, Joseph R; Fifer, William P
OBJECTIVE:To determine normative values for heart rate patterns in healthy fetuses. METHODS:This research is from the Safe Passage Study conducted by the Prenatal Alcohol and SIDS and Stillbirth (PASS) Network. A standardized protocol assessed fetal heart rate (FHR), heart rate variability (HRV), and movement from 1655 fetuses at three-time points during gestation (20-24 weeks, 28-32 weeks, 34-38 weeks gestation). RESULTS:FHR decreased while HRV increased over gestation. At the latter two ages, males had significantly lower FHR than females while there were no sex differences in FHR at 20-24 weeks. When accounting for the fetal state during late gestation (34-28 weeks), we found that males had significantly lower FHR than females in the active fetal state only. CONCLUSION:Results demonstrate significant state, gestational age, and sex-related changes in cardiac activity, somatic activity, and autonomic function as the fetus approaches birth.
PMCID:6483837
PMID: 30833637
ISSN: 1476-5543
CID: 5340462
Maternal Serotonin Levels Are Associated With Cognitive Ability and Core Symptoms in Autism Spectrum Disorder
Montgomery, Alicia K; Shuffrey, Lauren C; Guter, Stephen J; Anderson, George M; Jacob, Suma; Mosconi, Matthew W; Sweeney, John A; Turner, J Blake; Sutcliffe, James S; Cook, Edwin H; Veenstra-VanderWeele, Jeremy
OBJECTIVE:The serotonin (5-hydroxytryptamine [HT]) system has long been implicated in autism spectrum disorder (ASD). Whole-blood 5-HT level (WB5-HT) is a stable, heritable biomarker that is elevated in more than 25% of children with ASD. Recent findings indicate that the maternal 5-HT system may influence embryonic neurodevelopment, but maternal WB5-HT has not been examined in relation to ASD phenotypes. METHOD:WB5-HT levels were obtained from 181 individuals (3-27 years of age) diagnosed with ASD, 99 of their fathers, and 119 of their mothers. Standardized assessments were used to evaluate cognitive, behavioral, and language phenotypes. RESULTS: = 17.394, p < .001). Paternal and proband WB5-HT did not differ between classes. CONCLUSION:Maternal WB5-HT is associated with neurodevelopmental outcomes in offspring with ASD. Prospective, longitudinal studies will be needed to better understand the relationship between the function of the maternal serotonin system during pregnancy and brain development. Further studies in animal models may be able to reveal the mechanisms underlying these findings.
PMID: 30392628
ISSN: 1527-5418
CID: 5340452
Visually Evoked Response Differences to Contrast and Motion in Children with Autism Spectrum Disorder
Shuffrey, Lauren C; Levinson, Lisa; Becerra, Alexis; Pak, Grace; Moya Sepulveda, Dayna; Montgomery, Alicia K; Green, Heather L; Froud, Karen
High-density electroencephalography (EEG) was used to examine the utility of the P1 event-related potential (ERP) as a marker of visual motion sensitivity to luminance defined low-spatial frequency drifting gratings in 16 children with autism and 16 neurotypical children. Children with autism displayed enhanced sensitivity to large, high-contrast low-spatial frequency stimuli as indexed by significantly shorter P1 response latencies to large vs. small gratings. The current study also found that children with autism had larger amplitude responses to large gratings irrespective of contrast. A linear regression established that P1 adaptive mean amplitude for large, high-contrast sinusoidal gratings significantly predicted hyperresponsiveness item mean scores on the Sensory Experiences Questionnaire for children with autism, but not for neurotypical children. We conclude that children with autism have differences in the mechanisms that underlie low-level visual processing potentially related to altered visual spatial suppression or contrast gain control.
PMCID:6162529
PMID: 30149500
ISSN: 2076-3425
CID: 5340442
Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?
Shuffrey, Lauren C; Guter, Stephen J; Delaney, Shannon; Jacob, Suma; Anderson, George M; Sutcliffe, James S; Cook, Edwin H; Veenstra-VanderWeele, Jeremy
Approximately 30% of individuals with autism spectrum disorder (ASD) have elevated whole blood serotonin (5-HT) levels. Genetic linkage and association studies of ASD and of whole blood 5-HT levels as a quantitative trait have revealed sexual dimorphism. Few studies have examined the presence of a sex difference on hyperserotonemia within ASD. To assess whether the rate of hyperserotonemia is different in males than in females with ASD, we measured whole blood 5-HT levels in 292 children and adolescents with ASD, the largest sample in which this biomarker has been assessed. Based upon previous work suggesting that hyperserotonemia is more common prior to puberty, we focused our analysis on the 182 pre-pubertal children with ASD. 42% of pre-pubertal participants were within the hyperserotonemia range. In this population, we found that males were significantly more likely to manifest hyperserotonemia than females (P = 0.03). As expected, no significant difference was found in the post-pubertal population. Additional work will be needed to replicate this intriguing finding and to understand whether it could potentially explain differences in patterns of ASD risk between males and females. Autism Res 2017, 10: 1417-1423. © 2017 International Society for Autism Research, Wiley Periodicals, Inc.
PMCID:5568968
PMID: 28401654
ISSN: 1939-3806
CID: 5340432
MATERNAL WHOLE BLOOD SEROTONIN LEVELS PREDICT VERBAL ABILITY AND CORE SYMPTOMS IN CHILDREN WITH AUTISM SPECTRUM DISORDER [Meeting Abstract]
Montgomery, Alicia K.; Shuffrey, Lauren C.; Guter, Stephen J.; Anderson, George M.; Jacob, Suma; Sutcliffe, James S.; Turner, J. Blake; Cook, Edwin H.; Veenstra-VanderWeele, Jeremy
ISI:000544086201334
ISSN: 0890-8567
CID: 5340742